On Thursday, the British Medical Journal made their predictions as to what the future of medicine would be. These are the future “miracles” of medicine.“Picture a world where wheelchairs can climb stairs and insulin sacs implanted in diabetics automatically release just the right amount at the right time.”“Cures aren’t really our final destination,” said Dr.
SAN FRANCISCO — Experts have been pounding the same message over and over again for years – overuse of antibiotics has helped fuel the rise of drug-resistant “superbugs.”Yet the abuse of antibiotics remains a cause for concern and could even be on the rise, scientists and doctors told a drugs meeting here.“The prevalence of antibiotic-resistant
Strongest Antibiotic ApprovedFrom Associated PressToday, the FDA approved Synercid to treat vancomycin-resistant enterococcal infections, a life-threatening infection that typically strikes hospital patients. One recent study estimated as many as 52 percent of enterococcal infections are now vancomycin-resistant, making them difficult if not impossible to treat.The FDA also approved Synercid to treat certain complicated skin infections
An emerging strain of community-acquired MRSA underscores the complexity of the public health challenges associated with antibiotic resistance.
Federal health officials are worried that drug-resistant strains of staph bacteria may be spreading, after four Midwestern children died from infections.
On Thursday, the British Medical Journal made their predictions as to what the future of medicine would be. These are the future “miracles” of medicine.“Picture a world where wheelchairs can climb stairs and insulin sacs implanted in diabetics automatically release just the right amount at the right time.”“Cures aren’t really our final destination,” said Dr.
SAN FRANCISCO — Experts have been pounding the same message over and over again for years – overuse of antibiotics has helped fuel the rise of drug-resistant “superbugs.”Yet the abuse of antibiotics remains a cause for concern and could even be on the rise, scientists and doctors told a drugs meeting here.“The prevalence of antibiotic-resistant
Strongest Antibiotic ApprovedFrom Associated PressToday, the FDA approved Synercid to treat vancomycin-resistant enterococcal infections, a life-threatening infection that typically strikes hospital patients. One recent study estimated as many as 52 percent of enterococcal infections are now vancomycin-resistant, making them difficult if not impossible to treat.The FDA also approved Synercid to treat certain complicated skin infections
An emerging strain of community-acquired MRSA underscores the complexity of the public health challenges associated with antibiotic resistance.
Federal health officials are worried that drug-resistant strains of staph bacteria may be spreading, after four Midwestern children died from infections.